COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:

Search Results

One moment please while the data are loaded...
View results
  • Organ: Harderian Gland
  • Level of Evidence: Positive, Clear Evidence, Some Evidence
Displays results that match exactly with the given criteria.
Exact Match Publication No. CASRN Test Article Name Species Sex Route Organ Level of Evidence Tumor Type/Incidence Finding Type
Yes TR-100 135-20-6 Cupferron Mice Female Dosed-Feed Harderian Gland Positive ADENOMA Neoplastic Lesions
Yes TR-205 101-80-4 4,4'-Oxydianiline Mice Female Dosed-Feed Harderian Gland Positive (ADENOMA) Neoplastic Lesions
Yes TR-205 101-80-4 4,4'-Oxydianiline Mice Male Dosed-Feed Harderian Gland Positive (ADENOMA) Neoplastic Lesions
Yes TR-289 71-43-2 Benzene Mice Male Gavage Harderian Gland Clear Evidence ADENOMA 0/49 9/46 13/49 11/48 Neoplastic Lesions
Yes TR-326 75-21-8 Ethylene oxide Mice Female Inhalation Harderian Gland Clear Evidence CYSTADENOMA 1/46 6/46 8/47 Neoplastic Lesions
Yes TR-326 75-21-8 Ethylene oxide Mice Male Inhalation Harderian Gland Clear Evidence CYSTADENOMA 1/43 9/44 8/42 Neoplastic Lesions
Yes TR-374 556-52-5 Glycidol Mice Female Gavage Harderian Gland Clear Evidence ADENOMA 4/50 10/50 16/50 OR ADENOCARCINOMA 0/50 1/50 1/50 COMBINED 4/50 11/50 17/50 Neoplastic Lesions
Yes TR-374 556-52-5 Glycidol Mice Male Gavage Harderian Gland Clear Evidence ADENOMA 7/50 10/50 16/50 OR ADENOCARCINOMA 1/50 2/50 7/50 COMBINED 8/50 12/50 22/50 Neoplastic Lesions
Yes TR-384 96-18-4 1,2,3-Trichloropropane Mice Female Gavage Harderian Gland Clear Evidence ADENOMA 2/50 6/50 7/51 10/55 Neoplastic Lesions
Yes TR-384 96-18-4 1,2,3-Trichloropropane Mice Male Gavage Harderian Gland Clear Evidence ADENOMA 1/52 2/51 10/54 11/56 Neoplastic Lesions
Yes TR-340 5634-39-9 Iodinated glycerol Mice Female Gavage Harderian Gland Some Evidence ADENOMA 6/50 8/40 13/50 OR CARCINOMA 0/50 0/40 1/50 COMBINED 6/50 8/40 14/50 Neoplastic Lesions
Yes TR-352 924-42-5 N-Methylolacrylamide Mice Female Gavage Harderian Gland Clear Evidence ADENOMA 5/47 8/45 20/48 Neoplastic Lesions
Yes TR-352 924-42-5 N-Methylolacrylamide Mice Male Gavage Harderian Gland Clear Evidence ADENOMA 1/48 14/49 29/50 Neoplastic Lesions
Yes TR-467 126-99-8 Chloroprene Mice Female Inhalation Harderian Gland Clear Evidence ADENOMA 1/50 3/50 3/50 8/50 OR CARCINOMA 1/50 2/50 0/50 1/50 COMBINED 2/50 5/50 3/50 9/50 Neoplastic Lesions
Yes TR-467 126-99-8 Chloroprene Mice Male Inhalation Harderian Gland Clear Evidence ADENOMA 2/50 5/50 8/50 10/50 OR CARCINOMA 0/50 0/50 2/50 2/50 COMBINED 2/50 5/50 10/50 12/50 Neoplastic Lesions
Yes TR-461 75-52-5 Nitromethane Mice Female Inhalation Harderian Gland Clear Evidence ADENOMA 5/50 7/50 16/50 19/50 OR CARCINOMA 1/50 2/50 4/50 3/50 COMBINED 6/50 9/50 20/50 21/50 Neoplastic Lesions
Yes TR-461 75-52-5 Nitromethane Mice Male Inhalation Harderian Gland Clear Evidence ADENOMA 9/50 10/50 19/50 32/50 OR CARCINOMA 1/50 1/50 6/50 5/50 COMBINED 10/50 11/50 25/50 37/50 Neoplastic Lesions
Yes TR-434 106-99-0 1,3-Butadiene Mice Female Inhalation Harderian Gland Clear Evidence ADENOMA OR CARCINOMA 8/50 10/50 7/50 15/50 20/50 9/80 Neoplastic Lesions
Yes TR-434 106-99-0 1,3-Butadiene Mice Male Inhalation Harderian Gland Clear Evidence ADENOMA OR CARCINOMA 6/50 7/50 9/50 20/50 31/50 6/73, STOP STUDY 27/50 23/50 30/50 13/50 Neoplastic Lesions
Yes TR-452 3296-90-0 2,2-bis(Bromomethyl)-1,3-propanediol Mice Female Dosed-Feed Harderian Gland Clear Evidence ADENOMA 2/52 6/50 8/51 15/50 OR CARCINOMA 1/52 6/50 5/51 7/50 COMBINED 3/52 12/50 13/51 19/50 Neoplastic Lesions
Yes TR-452 3296-90-0 2,2-bis(Bromomethyl)-1,3-propanediol Mice Male Dosed-Feed Harderian Gland Clear Evidence ADENOMA 3/50 6/51 12/50 18/49 OR CARCINOMA 1/50 1/51 4/50 4/49 COMBINED 4/50 7/51 16/50 22/49 Neoplastic Lesions
Yes TR-506 107-13-1 Acrylonitrile Mice Female Gavage Harderian Gland Clear Evidence ADENOMA 10/50 10/50 25/50 23/50 ADENOMA OR CARCINOMA 11/50 10/50 26/50 25/50 Neoplastic Lesions
Yes TR-506 107-13-1 Acrylonitrile Mice Male Gavage Harderian Gland Clear Evidence ADENOMA 5/50 16/50 24/50 27/50 ADENOMA OR CARCINOMA 6/50 16/50 27/50 30/50 Neoplastic Lesions
Yes TR-510 51-79-6 Urethane Mice Female Dosed-Water Harderian Gland Clear Evidence ADENOMA 3/48 10/48 8/48 21/48 CARCINOMA 0/48 1/48 11/48 11/48 COMBINED 3/48 11/48 19/48 30/48 Neoplastic Lesions
Yes TR-510 51-79-6 Urethane Mice Male Dosed-Water Harderian Gland Clear Evidence ADENOMA 3/47 11/47 25/47 28/47 CARCINOMA 0/47 1/47 7/47 16/47 COMBINED 3/47 12/47 30/47 38/47 Neoplastic Lesions
Yes TR-588 5694-00-8 Glycidamide Mice Male Dosed-Water Harderian Gland Clear Evidence adenoma 3/47 17/47 23/47 32/46 42/47 Neoplastic Lesions
Yes TR-588 5694-00-8 Glycidamide Mice Female Dosed-Water Harderian Gland Clear Evidence adenoma 2/45 19/47 20/47 24/46 40/46 Neoplastic Lesions
Yes TR-594 98-56-6 p-Chloro-a,a,a-trifluorotoluene Mice Female Inhalation Harderian Gland Clear Evidence adenoma (2/50, 6/50, 6/50, 8/50); adenoma or adenocarcinoma (2/50, 6/50, 9/50, 8/50) Neoplastic Lesions
Yes TR-575 79-06-1 Acrylamide Mice Female Dosed-Water Harderian Gland Clear Evidence adenoma 0/45 8/44 20/48 32/47 31/43 Neoplastic Lesions
Yes TR-575 79-06-1 Acrylamide Mice Male Dosed-Water Harderian Gland Clear Evidence adenoma 2/46 13/46 27/47 36/47 39/47 adenocarcinoma 0/46 0/46 0/47 1/47 1/47 adenoma or adenocarcinoma 2/46 13/46 27/47 37/47 39/47 Neoplastic Lesions